Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Pulsed Field Ablation for Ventricular Arrhythmias: Current Evidence
Author(s): Serge Boveda , Andrea Sarkozy Added: 5 days ago
In the latest episode of Arrhythmia Academy’s Journal Club, Dr Serge Boveda (Clinic Pasteur, FR) is joined by Professor Andrea Sarkozy (Brussels South University Hospital, BE) to explore the evolving role of pulsed field ablation (PFA) in the treatment of ventricular arrhythmias.The discussion focuses on the potential of PFA as a novel energy source in the ventricle, examining its ability to… View more

Electrophysiology & Arrhythmia
Job title: Reader in Cardiovascular Physiology
Personal History Dr Jamie O'Driscoll is based in Canterbury, UK where he holds the position of Reader in Cardiovascular Physiology at Canterbury Christ Church University. Academic History Dr Jamie O'Driscoll, BSc (Hons), MSc (Hons), CertEd, PhD, graduated with a 1st class honours in Sport Science from Brunel University, where he went on to earn a distinction in his MSc in Health and… View more
Job title: Professor in the Department of Health and Exercise Science and Executive Director of Healthy Exercise and Lifestyle ProgramS (HELPS)
CardioNerds @AHA23: AZALEA-TIMI 71: Abelcibab Vs Rivaroxaban in Patients with AF
Author(s): Naima Maqsood , Christian Ruff Added: 2 years ago
AHA 23 - Dr Naima Maqsood, CardioNerds ambassador (Temple University Hospital, US) interviews Dr Christian Ruff (Brigham and Women's Hospital, US) on the late-breaking findings from the AZALEA-TIMI 71 randomized trial (Anthos Theraputics, Inc).AZALEA-TIMI 71 aimed to evaluate the bleeding profile of abelacimab as compared to rivaroxaban in patients with atrial fibrillation who are at moderate to… View more

Anticoagulation

Electrophysiology & Arrhythmia
Investigation of the Unexplained Cardiac Arrest Survivor
Author(s): Gonca Suna , Greg J Mellor Added: 2 years ago

Heart Failure

Electrophysiology & Arrhythmia
Etripamil in Paroxysmal Supraventricular Tachycardia Care: Highlights from Recent AHA Analyses
Author(s): Narendra Singh Added: 1 month ago
AHA 2025 — In this interview, Dr Narendra Singh (NSC Cardiology, Atlanta, US) reviews the latest AHA data on etripamil, an investigational intranasal, nondihydropyridine calcium channel blocker for the rapid self-termination of paroxysmal supraventricular tachycardia (PSVT).Dr Singh discusses the burden of PSVT, key findings from randomized and open-label studies, conversion rates with single and… View more

Electrophysiology & Arrhythmia
Job title: Professor of Medicine and Director of Cardiovascular Research
Maurizio Volterrani
Job title: Head of the Cardiological Rehabilitation Unit
Full Professor in of Exercise Science and Medicine at San Raffaele Telematic University of Rome. Head of the Cardiac Pulmonary Department at IRCCS San Raffaele in Rome. Prof Volterrani’s main research interests include heart failure, exercise training in cardiac rehabilitation, telemedicine, hyperkalaemia and kidney failure . He is and has been principal investigator in multiple international… View more
Job title: Medical Director of Cardiac Rehabilitation and Preventive Cardiology and Director of Exercise Laboratories
CardioNerds @AHA23: ARTESiA: Stroke Risk Reduction in Sub-Clinical AF: Apixaban vs Aspirin
Author(s): Naima Maqsood , Jeff Healey Added: 2 years ago
AHA 2023 — Dr Naima Maqsood, CardioNerds ambassador (Temple University Hospital, US) interviews investigator, Dr Jeff Healey (McMaster University, CA) to outline the findings from a phase 4 trial of apixaban to reduce thromboembolism in patients with subclinical atrial fibrillation (AF).ARTESiA (NCT01938248) aims to determine if apixaban in combination with aspirin can reduce the instance of… View more

Anticoagulation

Electrophysiology & Arrhythmia